We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+1.2%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$38.6B
AUM Growth
+$669M
(+1.8%)
Cap. Flow
+$1.61B
Cap. Flow
% of AUM
4.18%
Top 10 Holdings %
Top 10 Hldgs %
13.49%
Holding
2,814
New
394
Increased
941
Reduced
1,071
Closed
396
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$550M |
| 2 |
Eli Lilly
LLY
|
+$493M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$418M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$381M |
| 5 |
Meta Platforms (Facebook)
META
|
+$379M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$486M |
| 2 |
Pfizer
PFE
|
+$433M |
| 3 |
Apple
AAPL
|
+$430M |
| 4 |
Tesla
TSLA
|
+$401M |
| 5 |
Roku
ROKU
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.02% |
| 2 | Healthcare | 23.8% |
| 3 | Communication Services | 9.19% |
| 4 | Financials | 8.73% |
| 5 | Consumer Discretionary | 8.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZIXI
1051
DELISTED
Zix Corporation
ZIXI
| $2.93M | 0.01% |
414,300
+360,100
| +664% | +$2.6M |
|
1052
Carlyle Group
CG
$16.6B
| $2.92M | 0.01% |
+61,800
| New | +$2.96M |
|
|
HSII
1053
DELISTED
Heidrick & Struggles
HSII
| $2.92M | 0.01% |
65,457
+10,400
| +19% | +$438K |
|
|
AMRS
1054
DELISTED
Amyris Inc.
AMRS
| $2.92M | 0.01% |
212,621
+59,100
| +38% | +$846K |
|
1055
NBT Bancorp
NBTB
$2.74B
| $2.92M | 0.01% |
80,800
+73,800
| +1,054% | +$2.59M |
|
1056
Sutro Biopharma
STRO
$401M
| $2.92M | 0.01% |
15,430
+6,230
| +68% | +$1.18M |
|
1057
Bio-Techne
TECH
$11.2B
| $2.91M | 0.01% |
+24,000
| New | +$2.92M |
|
|
FFWM
1058
DELISTED
First Foundation Inc
FFWM
| $2.91M | 0.01% |
110,500
+24,900
| +29% | +$595K |
|
1059
Antero Midstream
AM
$10.4B
| $2.9M | 0.01% |
278,706
+107,806
| +63% | +$1.06M |
|
|
SEM
1060
DELISTED
Select Medical
SEM
| $2.89M | 0.01% |
148,109
+28,211
| +24% | +$560K |
|
|
BRG
1061
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
| $2.87M | 0.01% |
225,500
+160,915
| +249% | +$1.86M |
|
|
PENG
1062
Penguin Solutions Inc
PENG
$2.7B
| $2.85M | 0.01% |
128,200
-69,800
| -35% | -$1.67M |
|
|
PCH
1063
DELISTED
PotlatchDeltic
PCH
| $2.85M | 0.01% |
55,168
-11,000
| -17% | -$574K |
|
1064
Madrigal Pharmaceuticals
MDGL
$10.8B
| $2.84M | 0.01% |
35,640
-49,300
| -58% | -$4.26M |
|
1065
Marcus & Millichap
MMI
$1.16B
| $2.83M | 0.01% |
69,800
-16,500
| -19% | -$640K |
|
|
ARNA
1066
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $2.83M | 0.01% |
47,493
-39,300
| -45% | -$2.32M |
|
1067
Amkor Technology
AMKR
$12.4B
| $2.82M | 0.01% |
113,185
-101,700
| -47% | -$2.59M |
|
|
INOV
1068
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $2.82M | 0.01% |
+70,100
| New | +$2.65M |
|
1069
Lineage Cell Therapeutics
LCTX
$269M
| $2.8M | 0.01% |
1,112,366
-712,200
| -39% | -$1.83M |
|
|
JNCE
1070
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $2.8M | 0.01% |
376,500
+158,900
| +73% | +$984K |
|
1071
JB Hunt Transport Services
JBHT
$25.5B
| $2.79M | 0.01% |
16,700
+1,698
| +11% | +$290K |
|
|
SIC
1072
DELISTED
Select Interior Concepts, Inc. Class A Common Stock
SIC
| $2.79M | 0.01% |
193,700
+7,800
| +4% | +$99.1K |
|
|
FLXN
1073
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $2.79M | 0.01% |
457,744
-286,400
| -38% | -$1.79M |
|
|
CHMI
1074
Cherry Hill Mortgage Investment Corp
CHMI
$83M
| $2.79M | 0.01% |
314,335
+800
| +0.3% | +$7.37K |
|
|
STKL
1075
DELISTED
SunOpta
STKL
| $2.79M | 0.01% |
312,224
+36,100
| +13% | +$365K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q3 2021 Portfolio in Review
As of Q3 2021, Two Sigma Advisers held 2,814 positions worth $38.6B, up 1.8% from $37.9B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Two Sigma Advisers deployed $1.61B of net new capital in Q3 2021, opening 394 new positions and adding to 941 existing holdings. Its largest new stake was Danaher: 1,248,470 shares worth $337M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 20% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $486M trimmed.
- Two Sigma Advisers's largest Q3 2021 buy was Danaher: 1,248,470 shares worth $337M.
- Two Sigma Advisers added most to Microsoft in Q3 2021, an estimated $550M increase.
- Two Sigma Advisers's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $486M.
- Two Sigma Advisers fully exited Roku in Q3 2021, selling an estimated $374M.
- Two Sigma Advisers's ten largest holdings make up 13% of its $38.6B portfolio in Q3 2021.
- Two Sigma Advisers opened 394 new positions and closed 396 in Q3 2021.
- Two Sigma Advisers's portfolio value rose 1.8% quarter-over-quarter to $38.6B.
Based on Two Sigma Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.